🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/03/2023 | 107,15 | 107,31 | 103,49 | 104,10 | -3,02% | 3,57% | 26.402.100 |
| 16/03/2023 | 106,50 | 107,71 | 104,23 | 107,34 | -0,27% | 3,27% | 9.441.500 |
| 15/03/2023 | 106,48 | 108,03 | 105,57 | 107,63 | +0,62% | 2,31% | 10.942.700 |
| 14/03/2023 | 105,45 | 107,13 | 104,52 | 106,97 | +1,17% | 2,48% | 9.806.900 |
| 13/03/2023 | 104,47 | 108,84 | 104,40 | 105,73 | -1,82% | 4,25% | 10.687.100 |
| 10/03/2023 | 107,44 | 110,72 | 107,34 | 107,69 | +0,08% | 3,15% | 9.738.500 |
| 09/03/2023 | 109,30 | 109,90 | 107,11 | 107,60 | -0,63% | 2,55% | 5.842.500 |
| 08/03/2023 | 110,93 | 111,28 | 107,59 | 108,28 | -2,69% | 3,33% | 8.440.800 |
| 07/03/2023 | 111,77 | 112,18 | 110,72 | 111,27 | +0,15% | 1,31% | 13.805.300 |
| 06/03/2023 | 107,66 | 111,24 | 107,45 | 111,10 | +3,95% | 3,52% | 17.776.600 |
| 03/03/2023 | 107,38 | 107,39 | 106,13 | 106,88 | -0,12% | 1,17% | 6.124.300 |
| 02/03/2023 | 106,63 | 107,37 | 106,10 | 107,01 | +0,34% | 1,19% | 5.097.500 |
| 01/03/2023 | 105,96 | 107,55 | 105,96 | 106,65 | +0,39% | 1,50% | 6.099.000 |
| 28/02/2023 | 108,83 | 108,84 | 106,16 | 106,24 | -2,85% | 2,46% | 10.209.900 |
| 27/02/2023 | 110,03 | 110,13 | 108,52 | 109,36 | -0,48% | 1,46% | 5.654.800 |
| 24/02/2023 | 110,09 | 110,33 | 108,89 | 109,89 | -0,63% | 1,31% | 5.787.900 |
| 23/02/2023 | 109,26 | 111,24 | 109,10 | 110,59 | +1,31% | 1,96% | 6.922.800 |
| 22/02/2023 | 110,21 | 110,32 | 108,92 | 109,16 | +0,08% | 1,27% | 7.213.900 |
| 21/02/2023 | 108,90 | 109,88 | 108,63 | 109,07 | -0,41% | 1,15% | 6.741.500 |
| 17/02/2023 | 106,33 | 109,54 | 105,52 | 109,52 | +2,83% | 3,78% | 9.474.600 |
| 16/02/2023 | 106,82 | 107,46 | 106,23 | 106,51 | -1,09% | 1,15% | 5.959.300 |
| 15/02/2023 | 108,53 | 108,79 | 107,56 | 107,68 | -0,97% | 1,13% | 6.416.600 |
| 14/02/2023 | 109,95 | 110,00 | 108,19 | 108,74 | -0,74% | 1,65% | 6.983.900 |
| 13/02/2023 | 108,71 | 109,57 | 108,35 | 109,55 | +0,90% | 1,12% | 7.383.100 |
| 10/02/2023 | 106,97 | 108,77 | 106,87 | 108,57 | +1,73% | 1,78% | 7.609.600 |
| 09/02/2023 | 106,86 | 107,84 | 106,54 | 106,72 | +0,08% | 1,22% | 7.976.800 |
| 08/02/2023 | 105,81 | 107,52 | 105,32 | 106,64 | +0,91% | 2,08% | 8.596.300 |
| 07/02/2023 | 103,70 | 105,93 | 103,56 | 105,68 | +1,59% | 2,29% | 7.904.700 |
| 06/02/2023 | 103,43 | 104,62 | 102,84 | 104,03 | +1,06% | 1,72% | 9.054.500 |
| 03/02/2023 | 103,22 | 103,79 | 102,48 | 102,94 | -0,50% | 1,27% | 11.210.800 |